Literature DB >> 23816412

Recommended precaution procedures protect healthcare workers from Crimean-Congo hemorrhagic fever virus.

Mustafa Gokhan Gozel1, Ilyas Dokmetas, Atifet Yasemin Oztop, Aynur Engin, Nazif Elaldi, Mehmet Bakir.   

Abstract

OBJECTIVES: The Crimean-Congo hemorrhagic fever (CCHF) virus can spread from person to person and may cause nosocomial outbreaks among healthcare workers (HCWs). The US Centers for Disease Control and Prevention have recommended the use of personal protective equipment (PPE). We investigated the compliance of HCWs with PPE usage during the follow-up of patients, and also the number of risky contacts that occurred between patients and HCWs. We also aimed to determine the seroprevalence of CCHF virus in HCWs.
METHODS: This study was conducted at Cumhuriyet University Education and Research Hospital, a medical center located in a highly endemic area for CCHF where a total of 1284 confirmed CCHF patients were followed-up between 2002 and 2012. All HCWs who were at risk of CCHF virus contact and infection were included in the study. The compliance of the HCWs with PPE usage and the number of contacts that had occurred were recorded. HCW serum samples were analyzed for CCHF virus IgM and IgG by ELISA.
RESULTS: The total rates of PPE usage were 93.7% for gowns, 77.4% for gloves, and 38.9% for masks; the highest compliance was detected in the infectious diseases ward: 100%, 88.6%, and 82.9%, respectively. A total of four HCWs had a history of high-risk contact with contaminated material (two percutaneous exposure and two mucosal contacts), but the number of low-risk contacts was quite high. The total seroprevalence rate was only 0.53%.
CONCLUSIONS: Although the HCWs at our medical center have dealt with an extremely high number of CCHF patients during the last decade, the total seropositivity for CCHFV IgG was only 0.53%. This low rate may be a result of high compliance with PPE usage and also regular education programs.
Copyright © 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Crimean-Congo hemorrhagic fever; Healthcare workers; Seroprevalence; Turkey

Mesh:

Year:  2013        PMID: 23816412     DOI: 10.1016/j.ijid.2013.05.005

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  9 in total

1.  Direct healthcare costs for patients hospitalized with Crimean-Congo haemorrhagic fever can be predicted by a clinical illness severity scoring system.

Authors:  Ilkay Bozkurt; Mustafa Sunbul; Hava Yilmaz; Saban Esen; Hakan Leblebicioglu; Nicholas J Beeching
Journal:  Pathog Glob Health       Date:  2016-02-25       Impact factor: 2.894

2.  Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff.

Authors:  Jos H Verbeek; Blair Rajamaki; Sharea Ijaz; Christina Tikka; Jani H Ruotsalainen; Michael B Edmond; Riitta Sauni; F Selcen Kilinc Balci
Journal:  Cochrane Database Syst Rev       Date:  2019-07-01

3.  Contact Tracing for an Imported Case of Crimean-Congo Hemorrhagic Fever - Experience from a Tertiary Care Center in Kerala, South India.

Authors:  Ronnie Thomas; Flossy Mathew; Edwin Mathew Louis; Chithra Valsan; R Priyanka; Joe Thomas; Lucy Raphael
Journal:  Indian J Community Med       Date:  2019 Jul-Sep

Review 4.  Therapeutic management of Crimean-Congo haemorrhagic fever.

Authors:  Fernando de la Calle-Prieto; Alejandro Martín-Quirós; Elena Trigo; Marta Mora-Rillo; Marta Arsuaga; Marta Díaz-Menéndez; José Ramón Arribas
Journal:  Enferm Infecc Microbiol Clin (Engl Ed)       Date:  2017-06-29

5.  Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff.

Authors:  Jos H Verbeek; Blair Rajamaki; Sharea Ijaz; Riitta Sauni; Elaine Toomey; Bronagh Blackwood; Christina Tikka; Jani H Ruotsalainen; F Selcen Kilinc Balci
Journal:  Cochrane Database Syst Rev       Date:  2020-04-15

Review 6.  Effectiveness of Personal Protective Equipment for Healthcare Workers Caring for Patients with Filovirus Disease: A Rapid Review.

Authors:  Mona Hersi; Adrienne Stevens; Pauline Quach; Candyce Hamel; Kednapa Thavorn; Chantelle Garritty; Becky Skidmore; Constanza Vallenas; Susan L Norris; Matthias Egger; Sergey Eremin; Mauricio Ferri; Nahoko Shindo; David Moher
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240

7.  Control measures following a case of imported Lassa fever from Togo, North Rhine Westphalia, Germany, 2016.

Authors:  Clara Lehmann; Matthias Kochanek; Diana Abdulla; Stephan Becker; Boris Böll; Anne Bunte; Daniel Cadar; Arno Dormann; Markus Eickmann; Petra Emmerich; Torsten Feldt; Christina Frank; Jochen Fries; Martin Gabriel; Udo Goetsch; René Gottschalk; Stephan Günther; Michael Hallek; Dieter Häussinger; Christian Herzog; Björn Jensen; Felix Kolibay; Michael Krakau; Georg Langebartels; Toni Rieger; Lars Schaade; Jonas Schmidt-Chanasit; Edgar Schömig; Gundolf Schüttfort; Alexander Shimabukuro-Vornhagen; Michael von Bergwelt-Baildon; Ulrike Wieland; Gerhard Wiesmüller; Timo Wolf; Gerd Fätkenheuer
Journal:  Euro Surveill       Date:  2017-09

8.  Infection prevention and control practice for Crimean-Congo hemorrhagic fever-A multi-center cross-sectional survey in Eurasia.

Authors:  Tom E Fletcher; Abuova Gulzhan; Salih Ahmeti; Seif S Al-Abri; Zahide Asik; Aynur Atilla; Nick J Beeching; Heval Bilek; Ilkay Bozkurt; Iva Christova; Fazilet Duygu; Saban Esen; Arjun Khanna; Çiğdem Kader; Masoud Mardani; Faisal Mahmood; Nana Mamuchishvili; Natalia Pshenichnaya; Mustafa Sunbul; Tuğba Y Yalcin; Hakan Leblebicioglu
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

9.  The association between self-perceived proficiency of personal protective equipment and objective performance: An observational study during a bioterrorism simulation drill.

Authors:  Itay Fogel; Osant David; Chaya H Balik; Arik Eisenkraft; Lion Poles; Omri Shental; Michael Kassirer; Tal Brosh-Nissimov
Journal:  Am J Infect Control       Date:  2017-06-30       Impact factor: 2.918

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.